Literature DB >> 12539175

Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications.

Anurag Srivastava1, Ranju Ralhan, Jatinder Kaur.   

Abstract

Neovacularization is an essential step in the multistage progression of malignant melanoma. The onset of new blood vessel formation is ushered in by the release of VEGF and numerous other angiogenic molecules by the tumor cells. Human melanoma is unique among neoplasms that both avascular (early horizontal growth phase characterized by very slow progression and 99%, 10-year survival) and vascular (late radial and vertical growth phase associated with rapid growth, metastasis and death in many cases), phases are discernible by the naked eye. Although cell biologists have made great strides in unraveling the mechanisms involved in the laying down of tumor vasculature and the factors that inhibit it, clinicians treating melanoma have been rather slow to realize and utilize the full potential of suppressing the tumor blood flow to the best advantage of the patient. We suggest a consorted endeavor by all the melanoma experts across the globe to establish an "angiogenesis database" wherein they pool the blood flow and vascularity information along with Breslow's thickness, Clark's level of invasion, lymphatic and vascular invasion, regression, and outcome of their patients. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12539175     DOI: 10.1002/jemt.10259

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  10 in total

1.  A pilot study of bevacizumab and interferon-α2b in ocular melanoma.

Authors:  Kristan D Guenterberg; Valerie P Grignol; Kiran V Relekar; Kimberly A Varker; Helen X Chen; Kari L Kendra; Thomas E Olencki; William E Carson
Journal:  Am J Clin Oncol       Date:  2011-02       Impact factor: 2.339

Review 2.  Therapy for metastatic melanoma: the past, present, and future.

Authors:  Laura Finn; Svetomir N Markovic; Richard W Joseph
Journal:  BMC Med       Date:  2012-03-02       Impact factor: 8.775

3.  In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages.

Authors:  Chulhong Kim; Eun Chul Cho; Jingyi Chen; Kwang Hyun Song; Leslie Au; Christopher Favazza; Qiang Zhang; Claire M Cobley; Feng Gao; Younan Xia; Lihong V Wang
Journal:  ACS Nano       Date:  2010-08-24       Impact factor: 15.881

4.  A novel histochemical method for a simultaneous staining of melanin and collagen fibers.

Authors:  Víctor S Carriel; Jose Aneiros-Fernandez; Salvador Arias-Santiago; Ingrid J Garzón; Miguel Alaminos; Antonio Campos
Journal:  J Histochem Cytochem       Date:  2011-01-12       Impact factor: 2.479

5.  Toward in vivo biopsy of melanoma based on photoacoustic and ultrasound dual imaging with an integrated detector.

Authors:  Yating Wang; Dong Xu; Sihua Yang; Da Xing
Journal:  Biomed Opt Express       Date:  2016-01-05       Impact factor: 3.732

6.  Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.

Authors:  Domingo G Perez; Vera J Suman; Tom R Fitch; Thomas Amatruda; Roscoe F Morton; Shamim Z Jilani; Costas L Constantinou; James R Egner; Lisa A Kottschade; Svetomir N Markovic
Journal:  Cancer       Date:  2009-01-01       Impact factor: 6.860

7.  VEGF secretion is inhibited by interferon-alpha in several melanoma cell lines.

Authors:  Ene T Raig; Natalie B Jones; Kimberly A Varker; Kristen Benniger; Michael R Go; Jennifer L Biber; Gregory B Lesinski; William E Carson
Journal:  J Interferon Cytokine Res       Date:  2008-09       Impact factor: 2.607

8.  The role of VEGF in melanoma progression.

Authors:  Parvin Rajabi; Ali Neshat; Mozhgan Mokhtari; Mohammad A Rajabi; Mehdi Eftekhari; Payam Tavakoli
Journal:  J Res Med Sci       Date:  2012-06       Impact factor: 1.852

9.  The Roles of Angiogenesis in Malignant Melanoma: Trends in Basic Science Research over the Last 100 Years.

Authors:  D Dewing; M Emmett; R Pritchard Jones
Journal:  ISRN Oncol       Date:  2012-06-07

10.  Tumor-immune interaction, surgical treatment, and cancer recurrence in a mathematical model of melanoma.

Authors:  Steffen Eikenberry; Craig Thalhauser; Yang Kuang
Journal:  PLoS Comput Biol       Date:  2009-04-24       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.